Faron Pharmaceutical (Finland)

The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study

Geoff Bellingan, Mikael Maksimow, David C. Howell et al. · The Lancet Respiratory Medicine · 2013 · 148 citations

Medicine, Immunology, Pharmacology +11

Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome

V. Marco Ranieri, Ville Pettilä, Matti K. Karvonen et al. · JAMA · 2020 · 136 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial

Reetta Virtakoivu, Jenna H. Rannikko, Miro Viitala et al. · Clinical Cancer Research · 2021 · 53 citations · Full text

Life Sciences, Immunology, Oncology +17

Interferon beta-1a for COVID-19: critical importance of the administration route

Juho Jalkanen, Maija Hollmén, Sirpa Jalkanen · Critical Care · 2020 · 45 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Syndecan‐1 expression is upregulated in degenerating articular cartilage in a transgenic mouse model for osteoarthritis

Heli Salminen‐Mankonen, Anna‐Marja Säämänen, Markku Jalkanen et al. · Scandinavian Journal of Rheumatology · 2005 · 30 citations

Medicine, Molecular Biology, Pathology +17